<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Life sciences briefing: Tuesday, Sept. 11, 2007</title>
	<atom:link href="http://venturebeat.com/2007/09/11/life-sciences-briefing-tuesday-sept-11-2007/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2007/09/11/life-sciences-briefing-tuesday-sept-11-2007/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Wed, 25 Nov 2009 02:43:52 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: VentureBeat &#187; Life sciences briefing: Thursday, Nov. 15, 2007</title>
		<link>http://venturebeat.com/2007/09/11/life-sciences-briefing-tuesday-sept-11-2007/comment-page-1/#comment-635784</link>
		<dc:creator>VentureBeat &#187; Life sciences briefing: Thursday, Nov. 15, 2007</dc:creator>
		<pubDate>Thu, 15 Nov 2007 20:24:20 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2007/09/11/life-sciences-briefing-tuesday-sept-11-2007/#comment-635784</guid>
		<description>[...] N Spine acquired by Synthes for $30M &#8212; N Spine, a San Diego maker of spinal devices, was acquired by Switzerland&#8217;s Synthes for $30 million. The release is here. N Spine shareholders also stand to receive an additional $45 million in milestone payments if development of the company&#8217;s products proceeds as planned. Our previous coverage of N Spine&#8217;s fundraising is here. [...]</description>
		<content:encoded><![CDATA[<p>[...] N Spine acquired by Synthes for $30M &#8212; N Spine, a San Diego maker of spinal devices, was acquired by Switzerland&#8217;s Synthes for $30 million. The release is here. N Spine shareholders also stand to receive an additional $45 million in milestone payments if development of the company&#8217;s products proceeds as planned. Our previous coverage of N Spine&#8217;s fundraising is here. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
